BioNTech spokesperson: Vaccine could initially be imported to China

BERLIN, Nov 4 (Reuters) - BioNTech would initially import its COVID-19 vaccine into China if approvals are granted, said a spokesperson for the company on Friday, after German Chancellor Olaf Scholz said during a visit to Beijing that China would allow expatriates to receive the German company's vaccine.

(This story has been corrected to make statement contingent on future regulatory approval)

Reporting by Hans Seidenstucker, Writing by Miranda Murray, Editing by Paul Carrel

Our Standards: The Thomson Reuters Trust Principles.